These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29574528)

  • 1. MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series.
    Castagna MG; Marzocchi C; Pilli T; Forleo R; Pacini F; Cantara S
    J Endocrinol Invest; 2019 Jan; 42(1):97-100. PubMed ID: 29574528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.
    Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M
    Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.
    Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW
    Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules.
    Giannini R; Torregrossa L; Gottardi S; Fregoli L; Borrelli N; Savino M; Macerola E; Vitti P; Miccoli P; Basolo F
    Cancer Cytopathol; 2015 Aug; 123(8):461-70. PubMed ID: 26033834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis.
    Cantara S; Marzocchi C; Pilli T; Cardinale S; Forleo R; Castagna MG; Pacini F
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
    Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
    J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.
    Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR
    Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
    Miseikyte-Kaubriene E; Ulys A; Trakymas M
    Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Ancillary Techniques in Thyroid Cytology Specimens.
    Nishino M; Krane JF
    Acta Cytol; 2020; 64(1-2):40-51. PubMed ID: 30947167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of fine needle aspiration and non-aspiration cytology for diagnosis of thyroid nodules: A prospective, randomized, and controlled trial.
    Wang D; Fu HJ; Xu HX; Guo LH; Li XL; He YP; Bo XW; Zhao CK; Sun LP; Lu F; Zhang K; Wei Q
    Clin Hemorheol Microcirc; 2017; 66(1):67-81. PubMed ID: 28128748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initially non-diagnostic ultrasound-guided fine needle aspiration cytology of thyroid nodules: value and management.
    Chung J; Youk JH; Kim JA; Kwak JY; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2012 Mar; 53(2):168-73. PubMed ID: 21969700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
    Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
    Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Sonographic Characteristics and Afirma Gene Expression Classifier Results in Thyroid Nodules With Indeterminate Fine-Needle Aspiration Cytopathology.
    Zhu QL; Faquin WC; Samir AE
    AJR Am J Roentgenol; 2015 Oct; 205(4):861-5. PubMed ID: 26397337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of micro-ribonucleic acids in thyroid nodules and serum to discriminate between follicular adenoma and cancer in patients with a fine needle aspiration biopsy classified as suspicious for follicular neoplasm: A preliminary study.
    Świrta JS; Wątor G; Seweryn M; Kapusta P; Barczyński M; Wołkow P
    Adv Clin Exp Med; 2023 Sep; 32(9):997-1007. PubMed ID: 36897102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears.
    Titov SE; Demenkov PS; Ivanov MK; Malakhina ES; Poloz TL; Tsivlikova EV; Ganzha MS; Shevchenko SP; Gulyaeva LF; Kolesnikov NN
    Oncol Rep; 2016 Nov; 36(5):2501-2510. PubMed ID: 27666315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum MicroRNA-146b Expression for Malignancy Prediction in Euthyroid Patients with Indeterminate Thyroid Nodules.
    Abdelfadeil AO; Halawa MR; Zaky I; Samy M; Salem L; Bahaaeldin AM
    Egypt J Immunol; 2024 Jan; 31(1):40-47. PubMed ID: 38224034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.